Home / Clinical Laboratory / Laboratory Equipment / Clinical Analyzers / Point-of-Care Analyzer / Point-of-Care Analyzer Cholestech LDX™ CLIA Waived (Whole Blood)13454
Picture of Point-of-Care Analyzer Cholestech LDX™ CLIA Waived (Whole Blood)13454

Point-of-Care Analyzer Cholestech LDX™ CLIA Waived (Whole Blood)13454

Point-of-Care-Analyzer-Cholestech-LDX™-CLIA-Waived-(Whole-Blood)13454

SKU #

#851962

MPN #

13454

Brand

Abbott Rapid Dx North America LLC

Stock

In Stock

Quantity

100

Features

ANALYZER, CHOLESTECH STARTER KIT D/S

$1,744.10 USD

Attribute Name Attribute Value
McKesson # 851962
Manufacturer # 13454
Brand Cholestech LDX™
Manufacturer Abbott Rapid Dx North America LLC
Application Point-of-Care Analyzer
CLIA Classification CLIA Waived (Whole Blood)
Contents1 Analyzer with Manual and Optics Check
Dimensions 8-1/4 X 4-3/4 Inch
Sample Type Whole Blood / Serum / Plasma Sample
Test Name Lipid Profile, Glucose, Total Cholesterol, HDL and LDL Cholesterol, Triglycerides
Time To Results 5 Minute Results
UNSPSC Code 41115807

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • CLIA-Waived point of care testing for lipids (cholesterol) and blood glucose with results in 5 minutes
  • Lab-accurate quality: Meets National Cholesterol Education Program (NCEP) guidelines
  • Accurate and reproducible: Certified by the CDC’s LSP and CRMLN programs* (the lipid testing accuracy standards)
  • Rapid results: Immediate feedback enables on-the-spot CHD risk assessment and care decisions